CELSUS THERAPEUTICS PLC's ticker is CLTX and the CUSIP is 15119A202. A total of 10 filers reported holding CELSUS THERAPEUTICS PLC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $166,000 | -23.9% | 286,508 | 0.0% | 0.02% | -35.3% |
| Q1 2015 | $218,000 | -84.9% | 286,508 | -4.5% | 0.03% | -84.7% |
| Q4 2014 | $1,440,000 | -3.4% | 300,000 | +22.7% | 0.22% | -27.7% |
| Q3 2014 | $1,491,000 | +133.3% | 244,500 | +137.4% | 0.31% | +81.7% |
| Q2 2014 | $639,000 | -4.3% | 103,000 | 0.0% | 0.17% | +9.7% |
| Q1 2014 | $668,000 | – | 103,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 470,877 | $3,056,000 | 0.30% |
| DAFNA Capital Management LLC | 43,900 | $285,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 669,080 | $4,342,000 | 0.24% |
| Cormorant Asset Management, LP | 103,000 | $668,000 | 0.15% |
| Knoll Capital Management, LLC | 23,255 | $151,000 | 0.08% |
| Baker Brothers Advisors | 673,887 | $4,374,000 | 0.06% |
| UBS AG | 395 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 465 | $3,000 | 0.00% |
| CITIGROUP INC | 2,460 | $16,000 | 0.00% |
| MORGAN STANLEY | 7 | $0 | 0.00% |